Taysha Gene Therapies, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2024 | 18.68 M | $37.54 M | -11.94% | 6.97% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 18.65 M | $37.49 M | 0.00% | 6.96% |
| RTW INVESTMENTS, LP | 11/14/2024 | 14.95 M | $30.04 M | -20.50% | 5.58% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 13.52 M | $27.18 M | 100.00% | 5.05% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 10.87 M | $21.85 M | 0.00% | 4.06% |
| VR ADVISER, LLC | 11/14/2024 | 9.00 M | $18.09 M | 0.00% | 3.36% |
| VANGUARD GROUP INC | 11/13/2024 | 8.27 M | $16.61 M | 15.32% | 3.09% |
| MORGAN STANLEY | 11/14/2024 | 7.66 M | $15.40 M | 2.50% | 2.86% |
| SIREN, L.L.C. | 11/13/2024 | 4.88 M | $9.81 B | 100.00% | 1.82% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 4.57 M | $9.19 M | 0.00% | 1.71% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 4.00 M | $8.05 M | 0.00% | 1.50% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 11/14/2024 | 3.70 M | $7.44 M | 0.00% | 1.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 3.56 M | $7.16 M | 23.69% | 1.33% |
| STATE STREET CORP | 11/14/2024 | 3.47 M | $6.97 M | 4.54% | 1.30% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 3.03 M | $6.08 M | 0.00% | 1.13% |
| JPMORGAN CHASE & CO | 12/26/2024 | 3.00 M | $6.03 M | 1.28% | 1.12% |
| CITADEL ADVISORS LLC | 11/14/2024 | 2.86 M | $5.75 M | 6,004.01% | 1.07% |
| GHOST TREE CAPITAL, LLC | 11/14/2024 | 2.15 M | $4.32 M | 72.00% | 0.80% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2024 | 2.12 M | $4.26 M | -9.09% | 0.79% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.21 M | $2.42 M | 17.40% | 0.45% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 1.14 M | $2.29 M | 40.78% | 0.43% |
| WOODLINE PARTNERS LP | 11/14/2024 | 1.03 M | $2.07 M | 0.12% | 0.38% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 843,200 | $1.69 M | 9.62% | 0.31% |
| PALO ALTO INVESTORS LP | 11/14/2024 | 811,268 | $1.63 M | 0.00% | 0.30% |
| QUANTUM PRIVATE WEALTH, LLC | 10/31/2024 | 767,616 | $1.54 M | 5.08% | 0.29% |
| SANDS CAPITAL VENTURES, LLC | 11/13/2024 | 724,873 | $1.46 M | 0.00% | 0.27% |
| ALPHABET INC. | 11/08/2024 | 640,882 | $1.29 M | 0.00% | 0.24% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 566,850 | $1.14 M | -47.47% | 0.21% |
| MARSHALL WACE, LLP | 11/14/2024 | 486,026 | $976,911 | -38.17% | 0.18% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 463,192 | $931,016 | 100.00% | 0.17% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 462,867 | $930,363 | 7.71% | 0.17% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 352,684 | $708,895 | -44.24% | 0.13% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 338,272 | $679,926 | -25.57% | 0.13% |
| KOVITZ INVESTMENT GROUP PARTNERS, LLC | 11/15/2024 | 292,778 | $588,484 | 0.00% | 0.11% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 251,400 | $505,314 | 0.24% | 0.09% |
| BARCLAYS PLC | 11/19/2024 | 247,280 | $513,000 | 355.95% | 0.09% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 233,560 | $469,000 | 64.71% | 0.09% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 11/04/2024 | 206,992 | $416,054 | 100.00% | 0.08% |
| RHUMBLINE ADVISERS | 11/12/2024 | 186,248 | $374,349 | 1.07% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 176,492 | $354,749 | 36.60% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 133,735 | $268,807 | 7.87% | 0.05% |
| PRIVIUM FUND MANAGEMENT B.V. | 11/01/2024 | 120,000 | $241,200 | 21.83% | 0.04% |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 10/29/2024 | 118,175 | $232,805 | 1.09% | 0.04% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 108,250 | $217,583 | 13.23% | 0.04% |
| JANE STREET GROUP, LLC | 11/15/2024 | 107,572 | $216,220 | -16.04% | 0.04% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 103,123 | $207,277 | 28.49% | 0.04% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 100,795 | $200,582 | 100.00% | 0.04% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 92,098 | $185,117 | 7.02% | 0.03% |
| UBS GROUP AG | 11/14/2024 | 92,001 | $184,922 | 64.06% | 0.03% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 88,053 | $176,987 | 100.00% | 0.03% |
Taysha Gene Therapies, Inc.institutional Ownership - FAQ's
During the previous two years, 130 institutional investors and hedge funds held shares of Taysha Gene Therapies, Inc.. The most heavily invested institutionals were:
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC: 0
FMR LLC: 18.68 M
Avoro Capital Advisors LLC: 18.65 M
RTW INVESTMENTS, LP: 14.95 M
BlackRock Funding, Inc. /DE: 13.52 M
RA CAPITAL MANAGEMENT, L.P.: 10.87 M
58.59% of Taysha Gene Therapies, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 164.53 M shares in the last 24 months. This purchase volume represents approximately $268.19 M in transactions.